Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross M Maltz

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|July 1, 2024
Clinical impacts of immunomodulator withdrawal from anti-tumor necrosis factor combination therapy in pediatric inflammatory bowel diseaseNicholas A Iovino, Madeline G McClinchie, Mahmoud Abdel-Rasoul, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 11, 2019
Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel DiseaseAmy J Guido, Wallace Crandall, Emily Homan, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2019
Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis DRose Lee, Ross M Maltz, Wallace V Crandall, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 10, 2018
Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and OutcomesAla K Shaikhkhalil, Brendan Boyle, Jennifer Smith, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 28, 2023
Impact of Telemedicine on Delivery of Pediatric Inflammatory Bowel Disease CareHilary K Michel, Tyler J Gorham, Jennifer A Lee, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 2, 2020
Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel DiseaseHaley Pearlstein, Josh Bricker, Hilary K Michel, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 21, 2025
Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel diseaseNicole Davidson, Grant A Morris, Molly A Wright, et al.
The American Journal of Managed Care|October 27, 2025
The biosimilar shift: trending infliximab biosimilar utilization and associated cost savings for commercial insuranceSamantha R Paglinco, Mahmoud Abdel-Rasoul, Megan McNicol, et al.
Pediatric Blood & Cancer|October 21, 2025
Inflammatory Bowel Disease Following Allogeneic Hematopoietic Cell Transplant for Sickle Cell DiseaseEmily Rowland, Akshay Sharma, Samantha Paglinco, et al.
JPGN Reports|August 15, 2025
The Transition Care Index: Standardizing comprehensive transition and transfer for young adults with inflammatory bowel diseaseHilary K Michel, Jennifer L Dotson, Jennie G David, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Gastroenterology and Nutrition|July 1, 2024
Clinical impacts of immunomodulator withdrawal from anti-tumor necrosis factor combination therapy in pediatric inflammatory bowel diseaseNicholas A Iovino, Madeline G McClinchie, Mahmoud Abdel-Rasoul, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 11, 2019
Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel DiseaseAmy J Guido, Wallace Crandall, Emily Homan, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 21, 2019
Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis DRose Lee, Ross M Maltz, Wallace V Crandall, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 10, 2018
Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and OutcomesAla K Shaikhkhalil, Brendan Boyle, Jennifer Smith, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 28, 2023
Impact of Telemedicine on Delivery of Pediatric Inflammatory Bowel Disease CareHilary K Michel, Tyler J Gorham, Jennifer A Lee, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 2, 2020
Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel DiseaseHaley Pearlstein, Josh Bricker, Hilary K Michel, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 21, 2025
Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel diseaseNicole Davidson, Grant A Morris, Molly A Wright, et al.
The American Journal of Managed Care|October 27, 2025
The biosimilar shift: trending infliximab biosimilar utilization and associated cost savings for commercial insuranceSamantha R Paglinco, Mahmoud Abdel-Rasoul, Megan McNicol, et al.
Pediatric Blood & Cancer|October 21, 2025
Inflammatory Bowel Disease Following Allogeneic Hematopoietic Cell Transplant for Sickle Cell DiseaseEmily Rowland, Akshay Sharma, Samantha Paglinco, et al.
JPGN Reports|August 15, 2025
The Transition Care Index: Standardizing comprehensive transition and transfer for young adults with inflammatory bowel diseaseHilary K Michel, Jennifer L Dotson, Jennie G David, et al.
Pageof 5